Mayo Logo Patients diagnosed with advanced-stage prostate cancer can now be treated, or at least the following piece of information suggests so. Mayo Clinic experts assert that surgery proffers long-term survival rates for advanced prostate cancer patients. The study findings were concluded after examining people whose cancer had potentially spread beyond the prostate, known as cT3 prostate cancer.

The study included patients diagnosed and operated on between 1987 and 1997. This long-term follow-up investigation focused on analyzing the outcomes of radical prostatectomy or surgery to remove the prostate gland. As a result, an 80 percent survival rate for cT3 diagnoses at 20 years and 90 percent for cT2 was registered. cT2 is when cancer remains confined to the prostate alone.

“We are doing a much better job of identifying and expanding candidates for surgery, which results in better, longer outcomes for so many of our patients. We have confirmed that patients diagnosed with locally advanced prostate cancer can enjoy a long, cancer-free interval,” said R. Jeffrey Karnes, M.D., of Mayo Clinic’s Department of Urology.

In conclusion, it was affirmed that advanced-stage prostate cancer patients undergoing surgery have better survival rates. Scientists are conducting further investigations to analyze contemporary data. The findings apparently have great significance in the health world.

The study was presented at the American Urological Association Annual Meeting in Washington.